Mosaic ImmunoEngineering Inc. (PTSC)
Q2-CY2026Q1-CY2026Q4-CY2025Q3-CY2025Q2-CY2025Q1-CY2025Q4-CY2024Q3-CY2024Q2-CY2024Q1-CY2024Q4-CY2023Q3-CY2023Q2-CY2023Q1-CY2023Q4-CY2022Q3-CY2022Q2-CY2022Q1-CY2022Q4-CY2021Q3-CY2021Q2-CY2021Q1-CY2021Q4-CY2020Q3-CY2020Q2-CY2020Q1-CY2020Q4-CY2019Q3-CY2019Q2-CY2019Q1-CY2019Q4-CY2018Q3-CY2018Q2-CY2018Q1-CY2018Q4-CY2017Q3-CY2017Q2-CY2017Q1-CY2017Q4-CY2016Q3-CY2016Q2-CY2016Q1-CY2016Q4-CY2015Q3-CY2015Q2-CY2015Q1-CY2015Q4-CY2014Q3-CY2014Q2-CY2014
Balance Sheet Date2025-Dec-312025-Sep-302025-Jun-302025-Mar-312024-Dec-312024-Sep-302024-Jun-302024-Mar-312023-Dec-312021-Mar-312020-Aug-312020-May-312020-Feb-292019-Nov-302019-Aug-312019-May-312019-Feb-282018-Nov-302018-Aug-312018-May-312018-Feb-282017-Nov-302017-Aug-312017-May-312017-Feb-282016-Nov-302016-Aug-312016-May-312016-Feb-292015-Nov-302015-Aug-312015-May-312015-Feb-282014-Nov-302014-Aug-312014-May-31
Fiscal PeriodQ4-FY2025Q3-FY2025Q2-FY2025Q1-FY2025Q4-FY2024Q3-FY2024Q2-FY2024Q1-FY2024Q4-FY2023Q4-FY2021Q1-FY2021Q4-FY2020Q3-FY2020Q2-FY2020Q1-FY2020Q4-FY2019Q3-FY2019Q2-FY2019Q1-FY2019Q4-FY2018Q3-FY2018Q2-FY2018Q1-FY2018Q4-FY2017Q3-FY2017Q2-FY2017Q1-FY2017Q4-FY2016Q3-FY2016Q2-FY2016Q1-FY2016Q4-FY2015Q3-FY2015Q2-FY2015Q1-FY2015Q4-FY2014
Total Revenue3,094$0$0$0$0$0$0$0$0$60$0$
QoQ%.00%.00%.00%.00%.00%.00%(100.00%).00%.00%
YoY%.00%.00%.00%.00%.00%(100.00%).00%.00%.00%.00%.00%
Cost Of Revenue0$0$0$0$0$0$0$0$0$0$0$
Gross Profit3,094$0$0$0$0$0$0$0$0$60$0$
Gross Margin100.00%100.00%
Operating Expenses148,133$144,358$148,854$174,774$150,157$186,430$274,302$268,766$804,448$111,807$511$103,834$487,440$303,037$228,033$158,623$143,925$203,481$235,640$274,004$254,159$283,324$328,466$281,265$284,244$322,372$430,867$405,242$342,198$398,166$460,136$247,668$357,373$372,625$468,941$
Operating Income(148,133$)(144,358$)(148,854$)(174,774$)(150,157$)(186,430$)(274,302$)(268,766$)
Operating Margin
Interest Income
Interest Expenses
Income Before Tax(169,137$)(165,361$)(169,628$)(181,320$)(150,644$)(186,730$)(293,717$)(288,492$)(804,443$)(115,883$)(511$)(101,280$)(513,104$)(341,658$)(249,345$)(184,078$)(152,122$)(211,318$)(309,335$)(308,569$)(351,036$)(290,266$)(327,401$)(309,323$)967,024$(373,268$)(573,085$)(531,865$)(86,419$)(72,831$)(529,914$)24,313$(434,631$)(594,353$)(718,985$)
Tax Expenses0$0$2,400$2,400$0$0$0$0$1,600$0$0$0$1,600$0$(52,156$)0$2,400$0$0$0$2,400$0$0$0$2,400$(830$)0$0$2,400$(19,289$)
Net Income(169,137$)(165,361$)(172,028$)(181,320$)(153,044$)(186,730$)(293,717$)(288,492$)(806,843$)(115,883$)(511$)(101,280$)(513,104$)(343,258$)(249,345$)(184,078$)(152,122$)(212,918$)(309,335$)(256,413$)(351,036$)(292,666$)(327,401$)(309,323$)967,024$(375,668$)(573,085$)(531,865$)(86,419$)(75,231$)(535,191$)24,313$(434,166$)(593,953$)(651,219$)
Profit Margin(8,287.43%)(989,921.67%)
TTM(2,564,995.00%)(2,758,375.00%)(3,458,913.33%)(2,623,216.67%)
Earnings to Minority(969$)
Earnings to Common Shareholders(169,137$)(165,361$)(172,028$)(181,320$)(153,044$)(186,730$)(293,717$)(288,492$)(806,843$)(115,883$)(511$)(101,280$)(513,104$)(343,258$)(249,345$)(184,078$)(152,122$)(212,918$)(309,335$)(256,413$)(351,036$)(292,666$)(327,401$)(309,323$)967,024$(375,668$)(573,085$)(531,865$)(86,419$)(75,231$)(535,191$)25,282$(434,166$)(593,953$)(651,219$)
QoQ%(2.28%)3.88%5.13%(18.48%)18.04%36.43%(1.81%)(22,577.69%)99.50%80.26%(49.48%)(37.66%)(35.46%)(21.01%)28.55%31.17%(20.64%)26.96%(19.94%)10.61%(5.84%)(131.99%)357.42%34.45%(7.75%)(515.45%)(14.87%)85.94%(2,216.89%)105.82%26.90%8.79%(64.45%)
YoY%(10.52%)11.44%41.43%37.15%(157,794.91%)66.24%99.80%44.98%(237.30%)(61.22%)19.39%28.21%56.67%27.25%5.52%17.11%(136.30%)22.10%42.87%41.84%1,219.00%(399.35%)(7.08%)(2,203.73%)80.10%87.33%17.82%106.38%(745.58%)(21.99%)(138.14%)
Earnings Per Share, Basic(0.02$)(0.02$)(0.02$)(0.03$)(0.02$)(0.03$)(0.04$)(0.04$)(0.15$)0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$
Earnings Per Share, Diluted(0.02$)(0.02$)(0.03$)(0.02$)(0.03$)(0.04$)(0.04$)(0.15$)0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$
Unlevered FCF Per Share, Basic0.00$0.00$0.00$0.00$0.00$0.00$(0.02$)(0.01$)(0.03$)0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$
Unlevered FCF Per Share, Diluted0.00$0.00$0.00$0.00$0.00$(0.02$)(0.01$)(0.03$)0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$
Average Shares, Basic7,236,4477,236,4477,236,4477,236,4477,236,4477,236,4477,236,4477,236,4475,224,35747,652,516398,548,318398,548,318398,548,318398,548,318398,548,318398,548,318398,548,318398,548,318398,548,318398,548,318398,548,318395,703,688398,548,318398,548,318401,392,948395,703,688398,548,318398,548,318401,392,948395,703,688398,548,318398,548,318401,392,948399,431,298
Average Shares, Diluted7,236,4477,236,4477,236,4477,236,4477,236,4477,236,4477,236,4475,224,35747,652,516398,548,318398,548,318398,548,318398,548,318398,548,318398,548,318398,548,318398,548,318398,548,318398,548,318398,548,318392,859,058398,548,318401,392,948401,392,948395,703,688398,548,318398,548,318401,392,948401,392,948398,548,318401,392,948
EBIT(169,137$)(165,361$)(169,628$)(181,320$)(150,644$)(186,730$)(293,717$)(288,492$)(804,443$)(115,883$)(511$)(101,280$)(513,104$)(341,658$)(249,345$)(184,078$)(152,122$)(211,318$)(309,335$)(308,569$)(351,036$)(290,266$)(327,401$)(309,323$)967,024$(373,268$)(573,085$)(531,865$)(86,419$)(72,831$)(529,914$)24,313$(434,631$)(594,353$)(718,985$)
EBITDA(169,137$)(165,361$)(169,628$)(181,320$)(150,644$)(186,730$)(293,717$)(288,492$)(804,443$)(115,883$)(511$)(101,280$)(513,104$)(341,658$)(249,345$)(184,078$)(152,122$)(211,318$)(309,335$)(308,569$)(351,036$)(290,266$)(327,401$)(309,323$)967,024$(373,268$)(573,085$)(531,865$)(86,419$)(72,831$)(529,914$)24,313$(434,631$)(594,353$)(718,985$)